V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20225132 | 20085067 | 1.57 | 80 | Palliative (P) | 2017-08-18 | 2017-08-28 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101524455 |
| 20225134 | 20085068 | null | 88.3 | Neo-adjuvant (N) | 2019-07-05 | 2019-07-05 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101751588 |
| 20225135 | 20085069 | 1.58 | 51 | Palliative (P) | 2017-04-28 | 2017-04-30 | Enzalutamide | N | N | CARBOPLATIN | 100320242 |
| 20225139 | 20085070 | 1.73 | 81 | Palliative (P) | 2017-10-04 | 2017-10-04 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100957874 |
| 20225141 | 20085071 | 1.62 | 80.5 | Curative (C) | 2017-08-06 | 2017-08-11 | Enzalutamide | 02 | Y | CISPLATIN | 100819459 |
| 20225150 | 20085072 | 1.67 | 58.5 | null | 2016-04-25 | 2016-05-08 | Enzalutamide | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100457361 |
| 20225153 | 20085073 | 1.69 | 106 | Palliative (P) | 2016-05-06 | 2016-05-06 | Enzalutamide | 02 | N | CETUXIMAB | 101078862 |
| 20225159 | 20085074 | 1.68 | 58.8 | Palliative (P) | null | 2019-07-29 | Enzalutamide | 02 | N | OXALIPLATIN + RALTITREXED | 101659955 |
| 20225161 | 20085075 | 1.69 | 48 | null | 2017-12-22 | 2017-12-22 | Enzalutamide | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100192760 |
| 20225163 | 20085076 | 1.66 | 110 | Palliative (P) | 2019-09-21 | 2019-12-02 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100418202 |
| 20225168 | 20085077 | 1.7 | 121 | null | null | 2021-04-28 | Enzalutamide | 02 | null | CISPLATIN | 101024936 |
| 20225171 | 20085078 | 1.57 | 75.7 | Neo-adjuvant (N) | 2016-10-19 | 2019-01-06 | Enzalutamide | 02 | Y | OCTREOTIDE | 100950729 |
| 20225172 | 20085079 | 0 | null | Neo-adjuvant (N) | 2015-12-10 | 2015-12-17 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | null | ENZALUTAMIDE | 100227565 |
| 20225173 | 20085080 | 1.77 | 80.4 | Neo-adjuvant (N) | 2019-07-25 | 2019-07-26 | Enzalutamide | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101728732 |
| 20225183 | 20085081 | 1.77 | 182.5 | Palliative (P) | 2018-08-18 | 2018-09-10 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 101563198 |
| 20225190 | 20085082 | 1.72 | 76 | null | 2018-12-18 | 2019-01-03 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100876086 |
| 20225191 | 20085083 | 1.63 | 81.1 | null | 2017-09-16 | 2017-10-02 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101312830 |
| 20225193 | 20085084 | 1.56 | 79.3 | Palliative (P) | 2020-01-08 | 2020-01-26 | Enzalutamide | 02 | N | ECF | 101351626 |
| 20225194 | 20085085 | 0 | 0 | Neo-adjuvant (N) | 2016-12-11 | 2016-12-12 | Enzalutamide | N | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100153707 |
| 20225200 | 20085086 | 1.6 | 66.5 | null | 2020-02-26 | 2020-02-26 | Enzalutamide | 02 | Y | ECF | 100816228 |
| 20225202 | 20085087 | 0 | 0 | Neo-adjuvant (N) | 2018-11-17 | 2018-11-22 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 101428775 |
| 20225203 | 20085088 | 1.72 | 59.5 | Curative (C) | 2015-04-14 | 2015-04-16 | Enzalutamide | N | N | CISPLATIN | 101802109 |
| 20225204 | 20085089 | 1.69 | 43 | Palliative (P) | null | 2018-01-07 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101355674 |
| 20225207 | 20085090 | 1.68 | 78 | Palliative (P) | 2018-01-17 | 2018-02-07 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100290996 |
| 20225208 | 20085091 | 1.61 | 97 | Palliative (P) | 2019-09-29 | 2019-10-10 | Enzalutamide | 02 | N | ENZALUTAMIDE | 101410536 |
| 20225212 | 20085092 | 1.7 | 96.5 | null | 2016-08-14 | 2016-08-15 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100426952 |
| 20225216 | 20085093 | 1.72 | 71.6 | 03 | 2020-12-20 | 2020-12-20 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100563596 |
| 20225224 | 20085094 | 1.63 | 62.8 | Palliative (P) | 2017-02-25 | 2017-02-25 | Enzalutamide | 02 | N | CARBOPLATIN | 100076213 |
| 20225226 | 20085095 | 1.77 | 80.05 | Neo-adjuvant (N) | 2019-06-19 | 2019-06-19 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 101693648 |
| 20225233 | 20085096 | 1.88 | 80.6 | Palliative (P) | 2017-04-06 | 2017-04-22 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 101356498 |
| 20225236 | 20085097 | 1.66 | 73.4 | null | 2016-07-22 | 2016-08-28 | Enzalutamide | 02 | null | ATEZOLIZUMAB + BEVACIZUMAB | 100451649 |
| 20225244 | 20085098 | 1.79 | 75 | Palliative (P) | 2018-01-14 | 2018-01-14 | CARBOPLATIN + PACLITAXEL + RT | N | N | CARBOPLATIN + PACLITAXEL + RT | 101016738 |
| 20225247 | 20085099 | 1.57 | 117.5 | Curative (C) | 2018-05-05 | 2018-05-05 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100993150 |
| 20225248 | 20085100 | 1.91 | 0 | Neo-adjuvant (N) | 2017-04-08 | 2017-04-09 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | SCALOP-2 TRIAL | 101784518 |
| 20225255 | 20085101 | null | 79.8 | null | 2020-04-26 | 2020-05-13 | Enzalutamide | 02 | null | CAPECITABINE + TEMOZOLOMIDE | 100283052 |
| 20225259 | 20085102 | 1.78 | 0 | Curative (C) | 2017-11-06 | 2017-11-10 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN + RT | 101713983 |
| 20225263 | 20085103 | 1.55 | 106.4 | null | 2019-07-22 | 2019-07-23 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100429596 |
| 20225271 | 20085104 | 1.51 | null | Neo-adjuvant (N) | 2019-11-17 | 2019-12-09 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101802366 |
| 20225276 | 20085105 | 1.69 | 71.5 | Curative (C) | 2019-03-12 | 2019-04-11 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100898378 |
| 20225287 | 20085106 | 1.56 | 63 | Neo-adjuvant (N) | 2019-05-05 | 2019-06-10 | LUTETIUM-177 | 02 | Y | LUTETIUM-177 | 101459655 |
| 20225296 | 20085107 | 1.69 | 85 | Palliative (P) | 2017-07-04 | 2017-07-25 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100247571 |
| 20225308 | 20085108 | 1.6 | null | Neo-adjuvant (N) | 2017-07-26 | 2017-07-26 | ECF | 2 | N | ECF | 101107655 |
| 20225316 | 20085109 | 1.7 | 89 | Palliative (P) | 2019-05-16 | 2019-05-16 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 101453265 |
| 20225327 | 20085110 | 1.52 | 46.4 | Curative (C) | null | 2018-09-09 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 101220160 |
| 20225329 | 20085111 | 1.76 | 92.6 | Neo-adjuvant (N) | 2017-02-09 | 2017-02-09 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100276097 |
| 20225335 | 20085112 | 1.65 | 55.7 | Palliative (P) | 2018-07-10 | 2018-07-23 | OCTREOTIDE | 2 | N | OCTREOTIDE | 101063814 |
| 20225346 | 20085113 | 1.75 | 68.3 | 03 | 2016-10-08 | 2016-10-08 | Enzalutamide | null | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101697919 |
| 20225363 | 20085114 | 1.71 | 82.9 | Adjuvant (A) | 2019-05-15 | 2019-06-13 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100884214 |
| 20225367 | 20085115 | 1.69 | 55.3 | Palliative (P) | 2019-12-27 | 2020-01-17 | Cisplatin | 02 | N | CISPLATIN | 100468484 |
| 20225381 | 20085116 | 1.73 | 103 | null | 2019-07-18 | 2019-07-19 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100585594 |